Process for providing protective therapy for biological tissues or fluids
A process that provides protective therapy for biological tissues or fluids includes applying a pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease to therapeutically or prophylactically treat the target tissue or target fluid. The pulsed energy source has energy parameters selected so as to raise the target tissue or bodily target fluid temperature up to a predetermined temperature for a short period of time to achieve a therapeutic or prophylactic effect, while the average temperature rise of the target tissue or target fluid over a longer period of time is maintained at or below a predetermined level so as not to permanently damage the target tissue or target fluid.
1. A process for treating biological tissue or fluid having, or a risk of having, a chronic progressive disease, comprising the steps of:
providing a pulsed energy source having energy parameters including wavelength or frequency, duty cycle and pulse train duration; and
applying the pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease for the pulse train duration comprising less than one second to therapeutically treat the diseased target tissue or target fluid or prophylactically treat the target tissue or target fluid to prevent disease in the target tissue or target fluid;
wherein the pulsed energy source energy parameters are selected and the pulsed energy applied to the target tissue or target fluid so that the target tissue or the target fluid temperature is raised between six degrees Celsius to eleven degrees Celsius at least during application of the pulsed energy source to the target tissue or target fluid, but the target tissue or target fluid temperature several minutes after application of the pulsed energy source is only raised one degree Celsius or less to achieve a therapeutic or prophylactic effect while not permanently damaging the target tissue or target fluid; and
wherein the applying the pulsed energy source step comprises inserting a device into a cavity of a body to apply the pulsed energy source to the target tissue or target fluid.
2. The process of claim 1 , wherein the applying step comprises the step of stimulating heat shock protein activation in the target tissue or target fluid.
3. The process of claim 1 , wherein after a six minute period of time from the application of the pulsed energy source, the temperature of the target tissue or target fluid is raised one degree Celsius or less.
4. The process of claim 1 , wherein the pulsed energy source energy parameters are selected so that 20 to 40 joules of energy is absorbed by each cubic centimeter of the target tissue or target fluid.
5. The process of claim 1 , including the step of determining that the target tissue or target fluid has a chronic progressive disease or is at risk of having a chronic progressive disease.
6. The process of claim 1 , wherein the pulsed energy source is applied to a plurality of target tissue areas, and wherein adjacent target tissue areas are separated by at least a predetermined distance to avoid thermal tissue damage.
7. The process of claim 6 , wherein the applying the pulsed energy step comprises directing the pulsed energy source to an exterior of a body which is adjacent to the target tissue or has a target bodily fluid supply close to the surface of the exterior area of the body.
8. The process of claim 6 , wherein the pulsed energy is shifted and applied to the target tissue until the pulsed energy has been applied to all of the target tissue.
9. A process for treating biological tissue or fluid having, or a risk of having, a chronic progressive disease, comprising the steps of:
providing a pulsed energy source having energy parameters including wavelength or frequency, duty cycle and pulse train duration; and
applying the pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease for the pulse train duration comprising less than one second to therapeutically treat the diseased target tissue or target fluid or prophylactically treat the target tissue or target fluid to prevent disease in the target tissue or target fluid; and
wherein the pulsed energy source energy parameters are selected and the pulsed energy applied to the target tissue or target fluid so that the target tissue or the target fluid temperature is raised between six degrees Celsius to eleven degrees Celsius at least during application of the pulsed energy source to the target tissue or target fluid, but the target tissue or target fluid temperature several minutes after application of the pulsed energy source is only raised one degree Celsius or less to achieve a therapeutic or prophylactic effect while not permanently damaging the target tissue or target fluid; and
wherein the pulsed energy source comprises a radio frequency.
10. The process of claim 9 , wherein the pulsed energy source comprises a radio frequency between three to six megahertz, a duty cycle between 2.5% to 5%, and a pulse train duration between 0.2 to 0.4 seconds.
11. The process of claim 10 , wherein the radio frequency is generated with a device having a coil radii between 2 and 6 mm and between 13 and 57 amp turns.
12. A process for treating providing protective therapy for biological tissue or fluid having, or a risk of or having, a chronic progressive disease, comprising the steps of:
determining that a target tissue or target bodily fluid has a chronic progressive disease or is at risk of having a chronic progressive disease;
providing a radio frequency pulsed energy source having energy parameters including wavelength or frequency, duty cycle and pulse train duration; and
applying the pulsed energy source to the target tissue or the target fluid determined to have a chronic progressive disease or a risk of having a chronic progressive disease for the pulse train duration comprising less than one second to therapeutically treat the diseased target tissue or target fluid or prophylactically treat the target tissue or target fluid to prevent disease in the target tissue or target fluid;
wherein the energy parameters are selected and the pulsed energy applied to the target tissue or target bodily fluid so as to raise a target tissue or bodily target fluid temperature between six and eleven degrees Celsius at least during application of the pulsed energy to achieve a therapeutic or prophylactic effect but the average temperature rise of the target tissue or target fluid over several minutes is maintained at or below one degree Celsius so as to not permanently damage the target tissue or target bodily fluid; and
wherein the pulsed energy source comprises a radio frequency between three to six megahertz, a duty cycle between 2.5% to 5%, and a pulse train duration between 0.2 to 0.4 seconds.
13. The process of claim 12 , wherein the applying step comprises the step of stimulating heat shock protein activation in the target tissue or target fluid.
14. The process of claim 12 , wherein the average temperature of the target tissue or target fluid is maintained at one degree Celsius or less over a six minute period of time.
15. The process of claim 12 , wherein the pulsed energy source energy parameters are selected so that 20 to 40 joules of energy is absorbed by each cubic centimeter of the target tissue or target fluid.
16. The process of claim 12 , wherein the applying the pulsed energy source step comprises inserting a device into a cavity of a body to apply the pulsed energy source to the target tissue or target fluid.
17. The process of claim 12 , wherein the applying the pulsed energy step comprises directing the pulsed energy source to an exterior of a body which is adjacent to the target tissue or has a target bodily fluid supply close to the surface of the exterior area of the body.
18. The process of claim 12 , wherein the pulsed energy source is applied to a plurality of target tissue areas, and wherein adjacent target tissue areas are separated by at least a predetermined distance to avoid thermal tissue damage.
19. The process of claim 18 , wherein the pulsed energy is shifted and applied to the target tissue until the pulsed energy has been applied to all of the target tissue.
20. The process of claim 12 , wherein the radio frequency is generated with a device having a coil radii between 2 and 6 mm and between 13 and 57 amp turns.